$170.01 -2.73 (%) Amgen Inc - NASDAQ

Jul. 29, 2015 | 02:30 PM

Partner Headlines

  1. Gilead Gets Wall Street Love After Q2 Earnings Beat

    IBD | Jul. 29, 2015 | 12:29PM EST
  2. Amgen Stock Clears Buy Point Ahead Of Earnings

    IBD | Jul. 28, 2015 | 14:33PM EST
  3. Is More M&A On The Way For Large-Cap Biotechs?

    Benzinga | Jul. 28, 2015 | 13:18PM EST
  4. Biotech NantKwest Stock Surges On 1st Day Of Trading

    IBD | Jul. 28, 2015 | 12:08PM EST
  5. Benzinga's M&A Chatter for Monday July 27, 2015

    Benzinga | Jul. 27, 2015 | 18:39PM EST
  6. A Big Day For Biotech And It's Not Going So Well

    Benzinga | Jul. 27, 2015 | 13:10PM EST
  7. Regeneron/Sanofi PCSK9 Cholesterol Drug Wins FDA OK

    IBD | Jul. 24, 2015 | 16:11PM EST
  8. US Stock Futures Mixed; All Eyes On Apple, Microsoft Earnings

    Benzinga | Jul. 21, 2015 | 07:10AM EST
  9. Why Big Biotech Could Have Another Leg Up

    Benzinga | Jul. 17, 2015 | 10:49AM EST
  10. Perrigo Company Is Strong But Overvalued

    GuruFocus | Jul. 15, 2015 | 13:02PM EST
  11. Regeneron, Amgen Downgraded As Biotech Seen Slowing

    IBD | Jul. 9, 2015 | 11:12AM EST
  12. Benzinga's Top Downgrades

    Benzinga | Jul. 9, 2015 | 09:26AM EST
  13. Large-Cap Biotechs Poised For Second-Half Rally, RBC Says

    Benzinga | Jul. 9, 2015 | 09:21AM EST
  14. Benzinga's Top #PreMarket Losers

    Benzinga | Jul. 9, 2015 | 08:19AM EST
  15. UBS Downgrades Amgen On 'Waiting Game,' Removes Brodalumab From Model

    Benzinga | Jul. 9, 2015 | 08:15AM EST
  16. US Stock Futures Jump Ahead Of Jobless Claims Data

    Benzinga | Jul. 9, 2015 | 07:41AM EST
  17. What Is Beyond Vision-Loss Blockbuster For Regeneron?

    IBD | Jul. 1, 2015 | 16:12PM EST
  18. Amgen Among 3 Medical Giants With Healthy Payouts

    IBD | Jun. 30, 2015 | 18:33PM EST
  19. Evercore ISI Analyst Breaks Down Amgen's IPR Against AbbVie's Humira Formulation Patent

    Benzinga | Jun. 29, 2015 | 14:44PM EST
  20. Biotech Short-Sellers Prefer Amgen To Gilead Sciences

    Benzinga | Jun. 27, 2015 | 18:02PM EST
  21. Alder Bio Up As Credit Suisse Lauds Migraine Drug

    IBD | Jun. 24, 2015 | 15:49PM EST
  22. ProShares Releases 2 New Leveraged Biotech ETFs

    Benzinga | Jun. 23, 2015 | 15:38PM EST
  23. An Ebola-Fighting Portfolio For The Present...And The Future

    Benzinga | Jun. 19, 2015 | 10:04AM EST
  24. Teva Migraine Drug Succeeds In Midstage Trial

    IBD | Jun. 18, 2015 | 17:57PM EST
  25. Biotech ETFs Hit New 2015 Highs

    Benzinga | Jun. 18, 2015 | 14:20PM EST
  26. Teva Migraine Drug Succeeds In Midstage Trial

    IBD | Jun. 18, 2015 | 12:27PM EST
  27. Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks

    GuruFocus | Jun. 11, 2015 | 13:41PM EST
  28. Why Drugmaker AbbVie Can Power Past Patent Expiration

    IBD | Jun. 11, 2015 | 13:13PM EST
  29. New Migraine Drugs Could Ease Investors' Headaches

    IBD | Jun. 11, 2015 | 08:02AM EST
  30. FDA Cautious On New Drugs

    IBD | Jun. 10, 2015 | 18:51PM EST
  31. Amgen Cholesterol Drug Repatha Wins FDA Panel Vote

    IBD | Jun. 10, 2015 | 17:35PM EST
  32. Regeneron, Amgen Fall On Cholesterol Drug Worries

    IBD | Jun. 10, 2015 | 11:44AM EST
  33. FDA Panel Backs Regeneron

    IBD | Jun. 9, 2015 | 18:51PM EST
  34. Regeneron/Sanofi Cholesterol Drug Wins FDA Panel Vote

    IBD | Jun. 9, 2015 | 18:09PM EST
  35. FDA Looking at New Drugs to Lower "Bad" Cholesterol

    FoxBusiness | Jun. 9, 2015 | 09:15AM EST
  36. FDA weighs cholesterol fighter

    IBD | Jun. 8, 2015 | 19:01PM EST
  37. Are 4 Top-Rated IBD 50 Drug Stocks On Your Radar?

    IBD | Jun. 6, 2015 | 08:02AM EST
  38. FDA: Cholesterol Drug Works

    IBD | Jun. 5, 2015 | 18:38PM EST
  39. Regeneron/Sanofi Cholesterol Drug Under FDA Scrutiny

    IBD | Jun. 5, 2015 | 12:47PM EST
  40. PRIMECAP Sells Portions of Its Top Two Stakes

    GuruFocus | May. 27, 2015 | 19:36PM EST
  41. Amgen And AstraZeneca's Deal On Psoriasis Drug Faces Termination

    GuruFocus | May. 27, 2015 | 17:56PM EST
  42. 5 Drugs That Could Be Summer Blockbusters

    IBD | May. 27, 2015 | 15:54PM EST
  43. CNBC's Stock Pops & Drops From May 26

    Benzinga | May. 27, 2015 | 07:48AM EST
  44. Amgen's Cholesterol Fighting Drug Receives EU Approval

    GuruFocus | May. 26, 2015 | 16:46PM EST
  45. Amgen Down After Suicides Kill AstraZeneca Deal

    IBD | May. 26, 2015 | 12:39PM EST
  46. Morgan Stanley Found This 'Unexpected Negative' At Amgen

    Benzinga | May. 26, 2015 | 09:05AM EST
  47. 5 Drugs That Could Be Summer Blockbusters

    IBD | May. 26, 2015 | 08:02AM EST
  48. Amgen gets cholesterol edge

    IBD | May. 22, 2015 | 18:21PM EST
  49. Health Care Sector Delivers Healthy Q1 Results

    IBD | May. 15, 2015 | 18:13PM EST
  50. IPO Stock Watch: Alder Soars On Migraine Drug Results

    IBD | May. 15, 2015 | 16:31PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!